TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
Feb 06, 2026
2 min read
11

Philip Morris International (PMI) has projected a higher-than-expected adjusted earnings per share for 2026, forecasting a range of $8.38 to $8.53, which surpasses the analyst consensus of $8.33. The company also anticipates adjusted earnings growth of 11.1% to 13.1% for the current year. Despite this positive outlook, the company's shares declined by 2.9% in pre-market trading, reflecting investor unease.
The optimistic forecast is largely driven by the performance of smoke-free products, particularly the Zyn nicotine pouch. However, the brand faces escalating competition from rivals such as British American Tobacco, which is capturing a larger portion of category growth. This has fueled concerns regarding Zyn's long-term momentum, even as its U.S. volumes grew by 19% in the fourth quarter, supported by significant commercial activities.
Investor apprehension stems from PMI's strategy of using costly promotions to protect Zyn's market share, raising questions about profitability. An analyst from Bernstein noted that PMI's fourth-quarter results were mixed, with slightly lower revenues and a notable lack of specific guidance on U.S. Zyn growth. This absence of clear data is viewed negatively, intensifying fears of ongoing market share loss to competitors.
PMI plans to invest up to $1.6 billion to support the growth of its newer products, including Zyn and the heated tobacco device IQOS. This investment is critical as the company transitions away from traditional cigarettes. While the long-term financial targets appear robust, near-term market sentiment will likely depend on PMI's ability to maintain Zyn's market leadership profitably.
Q: Why did Philip Morris shares fall despite a strong profit forecast?
A: Shares fell due to investor concerns over intense competition for its Zyn nicotine pouch brand and the company's lack of specific growth guidance for the product in the U.S.
Q: What is PMI's adjusted earnings forecast for 2026?
A: The company forecasts full-year adjusted earnings per share to be between $8.38 and $8.53, which is above analysts' estimates.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles

06 Feb 2026
BMO's Top Agribusiness & Protein Stock Picks

06 Feb 2026
Turkey's BIST 100 Index Ends Lower by 0.49%